Northpond Ventures — Full Portfolio

Vizgen develops high-throughput spatial profiling technologies, including MERFISH-based spatial genomics and spatial proteomics tools for life science research and precision oncology.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesCambridge, US

GEGeorge Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inXZXiaowei Zhuang(Founder; Professor, Harvard University)inFenel Eloi(Director)RCRob Carson(Chief Executive Officer)inSimona Levi(Chief Legal Officer)in

Board seatSKSharon Kedar· per SEC Form D

Co-investorsARARCH Venture Partners6 6 Dimensions CapitalALAlly Bridge GroupAPApplied VenturesKIKilonova CapitalPUPura Vida Investments+3 more

Emulate builds Organ-on-a-Chip systems, including platforms, consumables, and pre-assembled BioKits with validated human cell models, to support drug discovery research.

BiotechDeep TechHealthtech

DIDonald Ingber(Scientific Founder, Board Member, Scientific Advisory Board Chairman)inDLDaniel Levner(Co-Founder & CTO)inJCJim Corbett(CEO, Board Member)inLELorna Ewart(Chief Scientific Officer)in

Co-investors+N+ND CapitalALAlwyn CapitalFOFourth RealmSTStray Dog CapitalOSOS FundSTStarlight Ventures

Inflammatix develops host-response-based molecular diagnostics tests to identify acute infections and sepsis in emergency and critical care settings.

AI & Machine LearningBiotechHealthtechMedical DevicesBurlingame, US

TSTim Sweeney(Co-Founder and CEO)inPKPurvesh Khatri(Co-Founder and Chief Scientist)inJRJONATHAN ROMANOWSKY(Executive Officer)in

BoardKENNETH BAHK(Director)MICHAEL RUBIN(Director)DAVID PERSING(Director)

Co-investorsKHKhosla VenturesINInitiate Venture PartnersOSOSF VenturesDFDFJ

Mestag is an immunology company developing first-in-class treatments for cancer and inflammatory diseases by leveraging novel understanding of fibroblast biology and tertiary lymphoid structures.

AI & Machine LearningBiotechDigital HealthHealthtechLondon, GB

Michael B. Brenner(Founder)Chris Buckley(Founder)MCMark Coles(Founder)inSRSoumya Raychaudhuri(Founder)DADavid A. Tuveson(Founder)SHSusan Hill(Chief Executive Officer)in

Co-investorsSVSV Health InvestorsFOForbionGVGV (Google Ventures)

Mestag Therapeutics is an immunology company developing first-in-class agonist antibody therapies for cancer and inflammatory diseases based on fibroblast biology, and operates a RAFT platform for discovering new drug targets.

AI & Machine LearningBiotechHealthtech

SHSusan Hill(Chief Executive Officer)inMichael B. Brenner(Founder)Chris Buckley(Founder)MCMark Coles(Founder)inSoumya Raychaudhuri(Founder)David A. Tuveson(Founder)

Co-investorsGVGV (Google Ventures)FOForbionJOJohnson & Johnson Innovation – JJDCSVSV Health InvestorsJJJJDC

Octave develops blood-based biomarker tests for neurodegenerative diseases including multiple sclerosis, Parkinson's disease, and Alzheimer's disease.

AI & Machine LearningBiotechDigital HealthMedical DevicesMenlo Park, US

WHWilliam Hagstrom(Founder and Chairman)inDBDoug Biehn(President and CEO)in

Co-investorsSASandbox IndustriesSESection 32BLBlue Venture FundsECEcho Health VenturesHIHikma VenturesGRGreycroft+1 more

OMass is a biotech company that originated as a spinout from Oxford University, developing specialized treatments for patient populations with high unmet medical needs.

BiotechDeep TechDigital HealthHealthtechMedical DevicesOxford, GB

PDProfessor Dame Carol Robinson(Founder and Chair of Scientific Advisory Board)ILIdlir Liko(Founder)inJHJonathan Hopper(Vice President, Platforms and Founder)inHYHsin Yung (Jason) Yen(Founder)inRDRos Deeganin

Co-investorsGVGV (Google Ventures)OXOxford Science EnterprisesSASanofi Ventures

QbDVision provides a software platform designed to address digital transformation challenges in pharmaceutical and biotech manufacturing, helping companies manage compliance, quality, and process development.

BiotechCloud ComputingEnterprise SoftwareHealthtechSaaSAustin, US

YSYash Sabharwal(President, CEO, Co-Founder)inRSRyan Shillington(CTO, CISO, Co-Founder)in

Co-investorsS3S3 VenturesCACartmell VenturesCRCREATE HEALTH VENTURES

Transition Bio applies methods from physics, chemistry, biology, and machine learning to study protein biophysics—including protein aggregation, self-assembly, and protein-protein interactions—for developing therapeutics targeting health and disease.

AI & Machine LearningBiotechDeep TechCambridge, US

TKTuomas Knowles(Executive Director, Co-Founder & Chief Technology Officer)SCSamuel Cohen(Executive Director & Co-Founder)inG. Kelly Martin(Executive Chairman & Co-Founder)George Martin(Executive Officer, Director)inStephanie Torruella(Executive Officer)inPreet Makkar(Executive Officer)

Co-investorsLILifeforce CapitalMAMagnetic VenturesTATaiho Ventures, LLCDODolby Family Ventures

VitalBio develops the VitalOne, a diagnostic device that delivers comprehensive lab-grade blood test results in minutes from a small blood sample, using robotics, biochemistry, computer vision, and microfluidics.

BiotechDigital HealthMedical Devices

VNVasu Nadella(Founder)in

Co-investorsNENext VenturesINInovia CapitalLALachy GroomMAMarc BenioffSASam Altman191955 Capital+6 more

Vizgen develops spatial profiling instruments and reagents for high-throughput analysis of gene expression and protein distribution in tissue samples.

AI & Machine LearningBiotechDeep TechMedical DevicesCambridge, US

GEGeorge Emanuel(Scientific Cofounder, VP & Portfolio Owner, Instruments)inJiang He(Scientific Cofounder, VP & Portfolio Owner, Reagents & Scientific Affairs)inRobert Carson(Executive Officer, Director)TLTerry Lo(Director)inSeth Benson(Executive Officer)inSimona Levi(Executive Officer)in

Co-investorsARARCH Venture PartnersM M VenturesILIllumina VenturesNONovalis LifeSciences

En Plus One Bio develops synthesis and manufacturing technology for RNA therapeutics, focused on producing high-purity long RNA with higher cycle efficiencies and novel chemical modifications.

BiotechDeep TechWatertown, US

DADaniel Ahlstedt(Executive Officer, Director)inJRJonathan Rittichier(Founder)in

BoardALAndrew Lee(Director)inSteven Kasok(Director)

Board seatPMPaxton Major· per SEC Form D

Co-investorsBRBreakout VenturesCOCoatue Management

IsoPlexis (now part of Bruker Cellular Analysis) provides single-cell functional profiling technology used to discover therapeutic antibodies, interrogate T cells for novel cell therapies, and accelerate cell line development.

BiotechDeep TechMedical DevicesNew Haven, US

Rong Fan(Director)Sean McKay(Executive Officer, Director)Sean Mackay(Executive Officer, Director)

BoardDaniel Wagner(Director)JCJohn Conley(Director)inGregory Ho(Director)

Board seatSKSharon Kedar· per SEC Form D · $85M raise · filed Jan 2021

Co-investorsALAlly Bridge Group

64x provides a platform and product suite for manufacturing advanced therapeutics, including gene therapies, cell therapies, and biologics.

BiotechDeep TechMedical Devices

Co-investorsBOBoxGroupFIFifty YearsFIFirst Round CapitalFUFuture VenturesLILifeforce CapitalRERefactor Capital+1 more

64x develops infrastructure and manufacturing systems for next-generation medicines, focusing on genetic engineering, cell line development, and computational biology to enable scalability of advanced therapies.

AI & Machine LearningBiotechDeep TechHealthtechMedical DevicesSan Francisco, US

LRLexi Rovner(Co-founder & CEO)in

Co-investorsFIFifty YearsFUFuture VenturesLILifeforce CapitalRARaptor GroupY Y CombinatorALAlix Ventures+4 more

Aro is a Brazilian technology platform that connects users with over 40 regulated credit partners to find personal loans, payroll (consignado CLT) loans, phone-collateral loans, and credit for people with negative credit records.

AI & Machine LearningB2B MarketplacesFintech

Co-investorsNONorte Ventures1717SigmaCOCowen Healthcare InvestmentsONOnevc Venture Partners Llc

Aro Biotherapeutics develops tissue-targeted genetic medicines using a proprietary protein technology called Centyrins.

BiotechHealthtechPhiladelphia, US

KOKaryn O'Neil(Executive Officer, Director)Susan Dillon(Founder)inMark V. Laurenzi(Executive Officer)

BoardElizabeth Anderson(Director)Bruce Peacock(Director)

Co-investorsAVAvego BioScience CapitalHEHealthCapAGAgent CapitalBIBiotechnology Value FundCOCowen Healthcare InvestmentsJOJohnson & Johnson Innovation – JJDC

QbDVision develops a Digital CMC (Chemistry, Manufacturing, and Controls) platform that captures structured product and process data to support end-to-end product lifecycle management from R&D through commercial manufacturing.

AI & Machine LearningBiotechSaaSAustin, US

Yashvinder Sabharwal(Executive Officer, Director)Ryan Shillington(Executive Officer, Director)

Co-investorsATATX Venture Partners

ChromaCode develops a High-Definition PCR (HDPCR) multiplexing platform that enables genomic solutions for oncology and precision medicine, offering faster results and cost-effective workflows through automated interpretation and cloud-based software.

AI & Machine LearningBiotechHealthtechMedical DevicesCarlsbad, US

PFPaul Flook(Executive Officer, Director)inGregory J. Gosch(Executive Officer, Director)Lynne Rollins(Executive Officer)Aditya Rajagopal(Director)inAxel Scherer(Director)

BoardJKJustin Klein(Director)in

Co-investorsADAdjuvant CapitalGLGlobal BrainMOMoore Venture PartnersNENew Enterprise Associates (NEA)WIWindham Capital PartnersDODomain Associates+2 more

Code Biotherapeutics develops a proprietary non-viral 3DNA delivery platform for genetic medicines, RNAi, and other modalities, using targeting molecules to reach specific cells and tissues outside the liver.

BiotechDeep TechHealthtechHatfield, US

Lauren Kaskiel(Executive Officer)inRobert C. Getts(Executive Officer)BMBrian McVeigh(Executive Officer, Director)in

BoardDmitry Kuzmin(Director)Victor Stone(Director)Edward Mathers(Director)

Co-investorsNENew Enterprise Associates (NEA)4B4BIO CapitalAMAmgen VenturesHAHatteras Venture PartnersJDJDRF T1D FundTATakeda Ventures+1 more

Culture Biosciences provides software and bioreactor hardware solutions for bioprocess development, enabling researchers to design, monitor, and analyze experiments remotely with cloud-native analytics and AI/ML insights.

AI & Machine LearningBiotechCloud ComputingHealthtechSan Francisco, US

WPWill Patrick(Founder/CEO)inMBMatt Ball(Founder/CTO)in

Co-investorsCOCompoundDCDCVC (Data Collective)GRGRIDS CapitalHEHemisphere Ventures LLCTHThe E14 FundY Y Combinator+4 more

Current Health builds FDA-cleared clinical technology and infrastructure that enables acute and complex care—including advanced therapies like CAR-T, bispecifics, and cell and gene therapies—to be delivered safely in ambulatory and home settings.

AI & Machine LearningDigital HealthHealthtechMedical DevicesEdinburgh, US

CMChristopher McGhee(Founder)in

Co-investorsLRLRVHealthMMMMC VenturesOSOSF VenturesSESection 32

Columbus, US

Tim Bowen(Executive Officer, Promoter)DBDave Billiter(Executive Officer, Director, Promoter)inSASimon Arkell(Executive Officer, Promoter)in

BoardMSMark Shary(Director)inJeffrey Elton(Director)

Co-investorsTATamarind HillRERev1 VenturesSISierra Ventures

Eleanor Health is an outpatient addiction treatment program that delivers remote evidence-based care for substance use disorder, including medication-assisted treatment and counseling.

Digital HealthHealthtechMental HealthWaltham, US

DNDr. Nzinga Harrison(Chief Medical Officer and Co-founder)CPCorbin Petro(Executive Officer, Director)Srishti Mirchandani(Executive Officer)in

BoardDWDavid Whelan(Director)inSonny Goyal(Director)KSKurt Sheline(Director)in

Co-investorsECEcho Health VenturesRERethink ImpactTOTown Hall VenturesGEGeneral CatalystWAWarburg Pincus

Elephas develops elive, a live-tissue platform technology that predicts immunotherapy response in cancer patients by measuring real-time immune activity in intact tumor tissue.

BiotechDigital HealthHealthtechMedical DevicesMadison, US

Jonathan Oliner(Executive Officer)inMAManeesh Arora(Founder)inMichelle B. Arora(Director)Terrence P. Brady(Executive Officer)

Co-investorsARARCH Venture PartnersSASands Capital Ventures

San Diego protein-sequencing company behind the ProteoCode platform; ceased operations in late 2025.

Co-investorsARARCH Venture PartnersDEDecheng CapitalALAlexandriaDEDeerfield Management CompanyGVGV (Google Ventures)NANan Fung Life Sciences

General Inception is an operational support and company building firm that handles day-to-day planning and execution for building companies, with a focus on life science tools and diagnostics.

Deep TechHealthtechMedical Devices

Co-investorsOMOMX VenturesPAPaladin Capital GroupGEGenoa VenturesVEVertical Venture Partners

BiotechPortola Valley, US

Lena Wu(Executive Officer, Director)Erik Gentalen(Director)Michael Rubin(Director)

BoardJRJenny Rooke(Director)in

Co-investorsVEVertical Venture PartnersGEGenoa Ventures

Kytopen develops non-viral gene delivery technology called Flowfect that combines fluid flow with electric fields to deliver payloads such as mRNA, DNA, and CRISPR Cas9 RNP into cells for high-throughput transfection.

BiotechDeep TechHardwareCambridge, US

CBCullen Buie(Director)inPGPaulo Garcia(Executive Officer, Director, Promoter)inMCMichael Chiu(Director, Executive Officer)in

BoardPMPaxton Major(Director)inADAnn DeWitt(Director)inPaul Wotton(Director)

Co-investorsBABantam GroupHOHorizons VenturesMAMassVenturesSESelvedge VentureTBTBD AngelsTETelegraph Hill Partners+2 more

Modern Systems Talk (MST) publishes content and insights on technology topics including system architecture, cloud computing, automation, AI, cybersecurity, and digital transformation.

Media & Entertainment

Co-investorsAGAgate Medical Investments LPSCSCP Vitalife PartnersFOForbionGVGV (Google Ventures)SVSV Health Investors

Opt Industries engineers advanced materials using digital photolithography to create structured materials with precise microstructure control, enabling functional properties across applications from high-speed interconnects to fluid handling.

Advanced ManufacturingDeep TechNew MaterialsMedford, US

JOJifei Ou(Founder)in

Co-investorsCRCrosslink CapitalGRGrit VenturesTHThe E14 FundBLBlumberg CapitalGRGradient Ventures

Ori develops expandable-unit technology for multifamily real estate, enabling hotel-to-housing conversions and ground-up developments that increase unit density while maintaining livability.

Construction TechHardwareImpact & Social GoodPropTech

Co-investorsINIngka InvestmentsPRPresidio VenturesTHThe E14 FundAMAmadeus Capital PartnersDEDelin VenturesKHKhosla Ventures+3 more

ORI provides an integrated business planning platform for supply chain professionals, combining demand planning, S&OP, S&OE, data analytics, and long-term planning in one tool.

AI & Machine LearningLogistics & Supply ChainSaaS

BSBrant Slade(Founder)in

Co-investorsKIKickstartAMAmadeus Capital PartnersDEDelin VenturesKHKhosla VenturesNONovalis LifeSciencesOCOctopus Ventures+2 more

Ori Biotech develops manufacturing automation platforms for cell and gene therapies, addressing scalability and cost barriers that limit patient access to these treatments.

Advanced ManufacturingBiotechDeep TechHardwareHealthtechMedical Devices

Co-investorsAMAmadeus Capital PartnersKIKindred CapitalNONovalis LifeSciencesDEDelin VenturesOCOctopus VenturesPUPuhua Capital

Outcomes4Me is an AI-driven patient platform that integrates with NCCN clinical oncology guidelines to provide personalized cancer care guidance, treatment options, clinical trial recommendations, and genetic testing information.

AI & Machine LearningDigital HealthHealthtechCambridge, US

MRMaya R. Said(Founder and CEO)inOsama Rahma(Founder)in

BoardAJAndrea Jackson(Director)inDavid Fleshman(Director)David Auckland(Director)

Co-investorsASAsset Management CompanyHEHealthX VenturesSISierra VenturesASAsset Management Ventures

Phia is an AI shopping assistant that compares prices across the web and secondhand marketplaces so shoppers can build their closet at the best price.

New York, US

SKSophia Kianni(Co-founder)inPGPhoebe Gates(Co-founder)in

BoardACAnnie Case(Director)in

Co-investorsCOCold Start VenturesDUDuke Capital PartnersKLKleiner PerkinsNONotable CapitalSCScribble VenturesKHKhosla Ventures

Scitara provides cloud-based integration and data management software for scientific laboratories, enabling connection of lab instruments and applications into a unified environment with AI-powered analytics.

AI & Machine LearningBiotechData & InfrastructureSaaSMarlborough, US

ANAjit Nagral(CEO & Chairman)inGGGeoff Gerhardt(Executive Officer, Promoter)inVPVinayak Purohit(Executive Officer)in

BoardCharles M. Hazard, Jr.(Director)AJAndrea Jackson(Director)inRohit Khanna(Director)

Co-investorsFLFlybridge Capital Partners

HealthtechCambridge, US

RDRahul Dhanda(Executive Officer, Director)inJCJames Collins(Director)David Walt(Director)in

BoardIRIssi Rozen(Director)in

Co-investorsCACatalio Capital Management, LPILIllumina VenturesCACatalio Capital ManagementGOGood VenturesGVGV (Google Ventures)NONovalis LifeSciences

SimBioSys builds AI-powered 3D visualization and diagnostic technology that models tumors as "digital twins" to support individualized cancer treatment planning.

AI & Machine LearningBiotechDigital HealthMedical DevicesChicago, US

JPJoe Peterson(Co-founder)John Cole(Co-founder)TPTushar Pandey(Co-founder)inSSStacey Stevens(Executive Officer, Director)in

BoardVCVikram Chaudhery(Director)inLCLucy Coassin(Director)

Co-investorsAVAV8 VenturesGEGenoa VenturesGEGENERAL INCEPTION

Slingshot Biosciences makes synthetic cell mimics used as standardized reference controls for flow cytometry and cell-based assays.

Emeryville, US

JKJeff Kim(Founder)inAdam Wieschhaus(Director)Ronald J. Silberman(Director)

BoardCRCorey Ritter(Director)in

Co-investorsARARCH Venture PartnersANAnterra Capital

AgTechEmeryville, US

EDEric Davidson(Director)inTBTravis Bayer(Director)inPBPaul Beck(Executive Officer)inDave Vosburg(Executive Officer)ALAdam Litle(Executive Officer, Director)inDNDerek Norman(Director)in

Co-investorsCACavallo VenturesCUCultivian Sandbox VenturesS2S2G InvestmentsFAFall Line CapitalFOFootPrint CoalitionLELeaps by Bayer+2 more

SpeeDx develops PCR-based diagnostic tests for sexually transmitted infections that detect pathogens and antibiotic resistance markers, enabling clinicians to make informed treatment decisions.

BiotechData & InfrastructureDigital HealthHealthtechMedical DevicesSydney, AU

ATAlison Todd(Co-founder)EMElisa Mokany(Co-founder)in

Co-investorsTETenmile

Palo Alto, US

Jonathan Hirsch(Executive Officer, Director)Glenn Winokur(Executive Officer, Director)Tony Loeser(Executive Officer)

BoardJKJohn Kuelper(Director)inChamath Palihapitiya(Director)Gary Kurtzman, M.D.(Director)

Co-investorsASAscension VenturesSOSocial Capital Partnership

Telesis Bio, Inc. is a company whose corporate governance page describes its Board of Directors and governance practices.

AI & Machine LearningBiotechDeep TechHardwareHealthtechSan Diego, US

DGDaniel G. Gibson(Executive Officer)inTRTodd R. Nelson(Executive Officer, Director)EEEric Esser(Executive Officer)inWilliam F. Snider(Director)ALAndrea L. Jackson(Director)inChristine A. Tsingos(Director)

Co-investorsNONovalis LifeSciences

BiotechCambridge, US

Shawn Marcell(Executive Officer, Director)BLBen Linden(Executive Officer)inDavid Yu Zhang(Director)Peng Yin(Director)

BoardAdam Wiechhaus(Director)

Co-investorsILIllumina Ventures

Triumvira is a clinical-stage immuno-oncology company developing autologous and allogeneic T cell therapeutics for cancer treatment.

BiotechHealthtechMedical DevicesAustin, US

TERESA MCROBERTS(Executive Officer)inPLPAUL LAMMERS, MD, MSc(Executive Officer, Director)inJIJON IRVIN(Executive Officer)in

BoardDANIEL JANSE(Director)JURGEN ECKHARDT(Director)ELIZABETH WILLIAMS(Director)

Co-investorsB B Capital GroupB4B4 CapitalCHCheckmate Capital Group LLCLELeaps by BayerOCOceanpine Capital

Uptime Health provides operational tools and preventive maintenance plans to healthcare practices to reduce downtime and ensure regulatory compliance.

Enterprise SoftwareHealthtechSaaSBoston, US

William Olsen(Executive Officer, Director)JPJinesh Patel(Executive Officer, Director)in

BoardJohn Huysmans(Director)

Co-investorsBABantam GroupC2C2 VenturesCACaduceus Capital PartnersDIDIAKLKluz VenturesOVOverline+6 more

Walking Fish Therapeutics develops cell therapies aimed at restoring health and function in patients.

AI & Machine LearningBiotechHealthtechMedical DevicesSouth San Francisco, US

Lewis Williams(Co-founder & CEO)inRusty Williams(Founder)Antonin de Fougerolles(Director)Momo Wu(Director)Stella Xu(Director)Alexis Ji(Director)

Co-investorsPAPandect BioventuresFIFirst Spark Ventures, Llc